Heather Brianne Dixon Sells 288 Shares of Addus HomeCare (NASDAQ:ADUS) Stock

Addus HomeCare Corporation (NASDAQ:ADUS) insider Heather Brianne Dixon sold 288 shares of the business’s stock in a transaction that occurred on Monday, June 22nd. The shares were sold at an average price of $93.77, for a total value of $27,005.76. Following the completion of the transaction, the insider directly owned 44,371 shares of the company’s stock, valued at $4,160,668.67. The trade was a 0.64% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Addus HomeCare Price Performance

Shares of NASDAQ ADUS opened at $97.20 on Thursday. The stock has a market capitalization of $1.81 billion, a price-to-earnings ratio of 17.97, a PEG ratio of 1.32 and a beta of 0.89. Addus HomeCare Corporation has a 12 month low of $87.95 and a 12 month high of $124.43. The firm’s 50 day simple moving average is $94.09 and its 200-day simple moving average is $101.85. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.83 and a quick ratio of 1.83.

Addus HomeCare (NASDAQ:ADUS) last posted its earnings results on Monday, May 4th. The company reported $1.62 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.52 by $0.10. The firm had revenue of $363.50 million during the quarter, compared to analysts’ expectations of $366.41 million. Addus HomeCare had a net margin of 6.89% and a return on equity of 9.80%. The business’s revenue was up 7.7% compared to the same quarter last year. During the same period in the previous year, the business posted $1.42 EPS. Analysts expect that Addus HomeCare Corporation will post 6.24 EPS for the current year.

Hedge Funds Weigh In On Addus HomeCare

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Capital Research Global Investors raised its position in shares of Addus HomeCare by 22.3% during the 4th quarter. Capital Research Global Investors now owns 1,469,752 shares of the company’s stock worth $157,837,000 after purchasing an additional 268,192 shares during the last quarter. Freestone Grove Partners LP boosted its holdings in Addus HomeCare by 5,035.2% in the 4th quarter. Freestone Grove Partners LP now owns 137,932 shares of the company’s stock worth $14,813,000 after buying an additional 135,246 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in Addus HomeCare by 11.8% in the 1st quarter. Dimensional Fund Advisors LP now owns 744,127 shares of the company’s stock worth $69,689,000 after buying an additional 78,415 shares during the last quarter. 8 Knots Management LLC purchased a new stake in Addus HomeCare during the 3rd quarter worth approximately $6,075,000. Finally, Empowered Funds LLC increased its stake in Addus HomeCare by 186.1% during the 4th quarter. Empowered Funds LLC now owns 70,927 shares of the company’s stock worth $7,617,000 after buying an additional 46,137 shares in the last quarter. 95.35% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on ADUS shares. Wall Street Zen lowered shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research note on Saturday, March 21st. Barclays cut their price target on Addus HomeCare from $102.00 to $92.00 and set an “underweight” rating for the company in a research note on Friday, May 15th. Stephens reduced their price target on Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating for the company in a report on Wednesday, February 25th. KeyCorp reiterated an “overweight” rating on shares of Addus HomeCare in a research report on Wednesday, February 25th. Finally, Weiss Ratings lowered Addus HomeCare from a “hold (c)” rating to a “hold (c-)” rating in a report on Friday, May 22nd. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $131.00.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.